Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma

Leukemia. 2005 Aug;19(8):1497-9. doi: 10.1038/sj.leu.2403811.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Aged
  • Drug Resistance, Neoplasm
  • Humans
  • Male
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • RNA, Messenger / analysis
  • RNA, Messenger / drug effects
  • Thalidomide / therapeutic use*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • RNA, Messenger
  • Thalidomide